Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Hematology and Oncology"
DOI: 10.1080/08880018.2021.1894280
Abstract: Abstract Cardiovascular complications represent the main determinant of survival in patients with hemoglobinopathies. Serum cystatin C is a well-known marker of nephropathy in sickle cell disease (SCD) and β-thalassemia patients that has recently emerged as… read more here.
Keywords: cardiovascular dysfunction; thalassemia; scd thalassemia; cystatin ... See more keywords
Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022006982
Abstract: High rates of alloimmunization have been observed among patients requiring chronic red blood cell (RBC) transfusions, especially those with sickle cell disease (SCD) and thalassemia. 1-3 Alloimmunization in SCD increases the risk of hemolytic transfusion… read more here.
Keywords: red cell; cell; scd thalassemia; cell alloimmunization ... See more keywords